FDA Commissioner Margaret Hamburg returned from her trip to India talking up cooperation and collaboration between regulators there and the FDA. Not all regulators there, however, sounded as enthusiastic as she did. Hamburg said that India's involvement the U.S. drug market "is why it is so important that the Indian regulator really joins us at the table." But G.N. Singh, the Drug Controller General of India, told Reuters that while he sees some areas for cooperating on more stringent manufacturing standards, "We don't recognize and are not bound by what the U.S. is doing and is inspecting." Story | More